Tag: Abbott

VIVA 2019: ABSORB BVS achieves “excellent” long-term patency and freedom from...

Ramon Varcoe today announced positive five-year results of the ABSORB BTK trial at the 2019 Vascular Interventional Advances conference (VIVA) in Las Vegas, USA...

VIVA 2019: CFA disease can be treated endovascularly with Supera stent

Two-year data confirm that common femoral artery (CFA) disease can be treated endovascularly with the Supera stent (Abbott). Results of the VMI-CFA study were...

Perclose ProGlide suture-mediated closure system FDA approval

Abbott has gained FDA approval for its Perclose Proglide suture-mediated closure system. The device is designed to close access sites created by large bore...

Surmodics partners with Abbott to develop their next-generation DCB

Abbott and Surmodics have announced an agreement whereby Abbott will have exclusive worldwide commercialisation rights for Surmodics' SurVeil drug-coated balloon (DCB) to treat the superficial...

InspireMD announces expansion of its distribution network for CGuard EPS

InspireMD has announced it has signed Diverse Devices as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production...

Analysis of percutaneous large-bore arterial access closure shows fewer adverse outcomes...

Percutaneous closure of large-bore arterial access sites using the Perclose ProGlide suture-mediated closure device (Abbott Vascular) is associated with significantly lower rates of blood...

SUPERSUB trial update and precise stent placement with the Presto technique

At LINC 2017 (24–27 January, Leipzig, Germany), Luis Mariano Palena (Policlinico Abano Terme, Abano Terme, Italy) presented an update on the SUPERSUB trial, which...

Terumo completes acquisition of vascular closure business and other assets of...

Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical. Terumo has acquired the Angio-Seal and...

Abbott completes the acquisition of St Jude Medical

Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...

Abbott acquisition of St Jude Medical set to close on 4...

Abbott has announced its intention to close the acquisition of St Jude Medical on Wednesday, 4 January 2017. The announcement follows receipt of all...

Terumo signs to acquire St Jude Medical and Abbott’s vascular closure...

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion. Based...

St Jude Medical shareholders approve merger with Abbott

St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October, St...

SUPERFAST results show advantage of Supera for chronic total occlusions

New data from a propensity matched prospective study suggest the Supera stent (Abbott Vascular) delivers superior results when compared to older generation nitinol stents...

St Jude Medical and Abbott to sell portion of vascular closure...

Abbott and St Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a purchase price of...